These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29778321)

  • 1. Submandibular gland sparing when irradiating neck level IB in the treatment of oral squamous cell carcinoma.
    Jackson WC; Hawkins PG; Arnould GS; Yao J; Mayo C; Mierzwa M
    Med Dosim; 2019 Summer; 44(2):144-149. PubMed ID: 29778321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-effect relationships for the submandibular salivary glands and implications for their sparing by intensity modulated radiotherapy.
    Murdoch-Kinch CA; Kim HM; Vineberg KA; Ship JA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):373-82. PubMed ID: 18337023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level IB nodal involvement in oropharyngeal carcinoma: implications for submandibular gland-sparing intensity-modulated radiotherapy.
    Yu Y; Daly ME; Farwell DG; Luu Q; Gandour-Edwards R; Donald PJ; Chen AM
    Laryngoscope; 2015 Mar; 125(3):608-14. PubMed ID: 25215891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sparing bilateral neck level IB in oropharyngeal carcinoma and xerostomia outcomes.
    Tam M; Riaz N; Kannarunimit D; Peña AP; Schupak KD; Gelblum DY; Wolden SL; Rao S; Lee NY
    Am J Clin Oncol; 2015 Aug; 38(4):343-7. PubMed ID: 26208401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Submandibular gland-sparing radiation therapy for locally advanced oropharyngeal squamous cell carcinoma: patterns of failure and xerostomia outcomes.
    Gensheimer MF; Liao JJ; Garden AS; Laramore GE; Parvathaneni U
    Radiat Oncol; 2014 Nov; 9():255. PubMed ID: 25424729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectively sparing the submandibular gland when level Ib lymph nodes are included in the radiation target volume: An initial safety analysis of a novel planning objective.
    Varra V; Ross RB; Juloori A; Campbell S; Tom MC; Joshi NP; Woody NM; Ward MC; Xia P; Koyfman SA; Greskovich JF
    Oral Oncol; 2019 Feb; 89():79-83. PubMed ID: 30732963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treatment techniques for reduction in the submandibular gland dose: A retrospective study.
    Hoyne C; Dreosti M; Shakeshaft J; Baxi S
    J Med Radiat Sci; 2017 Jun; 64(2):125-130. PubMed ID: 28240447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
    Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
    Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sparing the contralateral submandibular gland without compromising PTV coverage by using volumetric modulated arc therapy.
    Doornaert P; Verbakel WF; Rietveld DH; Slotman BJ; Senan S
    Radiat Oncol; 2011 Jun; 6():74. PubMed ID: 21679401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
    Little M; Schipper M; Feng FY; Vineberg K; Cornwall C; Murdoch-Kinch CA; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1007-14. PubMed ID: 22056067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Submandibular gland sparing in intensity-modulated radiotherapy for N0-stage nasopharyngeal carcinoma.
    Huang L; Zhang W; Zhuang T; Wu F; Li D; Zheng M; Lin B; Zhuang M; Chen Z
    Br J Radiol; 2014 Apr; 87(1036):20130651. PubMed ID: 24620926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
    Vallard A; Guy JB; Mengue Ndong S; Vial N; Rivoirard R; Auberdiac P; Méry B; Langrand-Escure J; Espenel S; Moncharmont C; Ben Mrad M; Diao P; Goyet D; Magné N
    Head Neck; 2016 Jul; 38(7):1028-34. PubMed ID: 26855006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study.
    Saibishkumar EP; Jha N; Scrimger RA; MacKenzie MA; Daly H; Field C; Fallone G; Parliament MB
    Radiother Oncol; 2007 Oct; 85(1):98-104. PubMed ID: 17923162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of contralateral submandibular gland sparing in locally advanced oropharyngeal cancers: A multicenter review.
    Robin TP; Gan GN; Tam M; Westerly D; Riaz N; Karam SD; Lee N; Raben D
    Head Neck; 2016 Apr; 38(4):506-11. PubMed ID: 25482748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Submandibular gland transfer for the prevention of radiation-induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era.
    Kutuk T; McAllister NC; Rzepczynski AE; Williams A; Young G; Crawley MB; Rabinowits G; Kaiser A; Contreras JA; Kalman NS
    Head Neck; 2022 May; 44(5):1213-1222. PubMed ID: 35243719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis to submandibular glands in oral cavity cancers: Can we preserve the gland safely?
    Panda NK; Patro SK; Bakshi J; Verma RK; Das A; Chatterjee D
    Auris Nasus Larynx; 2015 Aug; 42(4):322-5. PubMed ID: 25724734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of submandibular gland preservation during level 1B neck dissection on postoperative xerostomia.
    Markey JD; Morrel WG; Wang SJ; Ryan WR
    Auris Nasus Larynx; 2018 Feb; 45(1):123-127. PubMed ID: 28449980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.